International Health Science Srl (IHS), a newly-born company from the carve-out of Giellepi Finished Product business unit now incorporated in Biofarma Group, is a global leader in developing and offering ready-to-market, private label nutraceuticals, supplements and medical devices. Since 1998, research, development and high propensity to introduce new-to-the-market product innovations with claims backed by science is in the company’s DNA. Key benefit claims and safety of IHS’ products are supported by well-designed clinical trials among the targeted population made in collaboration with international KOLs working in hospitals and universities.
IHS headquarter includes a state-of-the art R&D facility dedicated to the creation of unique finished formulations in traditional delivery forms such as powders, tablets and capsules as well as novel dosage forms such as liquid gels, gummies and chewable tablets.
IHS represents an ideal partner for supplements and pharmaceutical companies looking for added-value products fundamental for building a successful global brand.
International Health Science is part of Biofarma Group, a leading international Contract Development and Manufacturing Organisation (CDMO). The group is an Italian and European market leader in the development, manufacture and packaging of supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties. Innovation, production excellence and a highly professional team are the values behind this new industrial project. The expertise that makes up each company in the Group, which comprises 4 production sites located in Lombardy, Veneto and Friuli Venezia Giulia, enables Biofarma Group to offer customised solutions and an even more complete and transversal service, ranging from the development of the idea to the finished product, as well as an extensive catalogue of products including dossiers, some of which are patented, available for out-licensing to customers with the possibility of being marketed worldwide.
Among the products currently offered by IHS there are:
Respecta® , a proprietary probiotic combination extensively tested in women to restore and maintain healthy vaginal microbiota. Indicated for the treatment of vaginitis, vaginosis and state of vaginal dysbiosis.
Respecta® Balance Gel, a medical device adjuvant in the treatment of vaginitis and vaginosis specifically studied for rebalancing the physiological pH and vaginal microbiota.
Respecta® Hydra Gel, a medical device with moisturizing and lubricant action recommended for the treatment and prevention of vaginal dryness.
RefluG™, a raft-forming medical device based on a proprietary mixture of natural ingredients for the relief of gastroesophageal reflux symptoms.
RefluG Isorepair™, a patented medical device studied for the esophageal mucosal defence and treatment of gastroesophageal reflux symptoms.
Lenoid™ cream (medical device), a gentle formula free from corticosteroids and anesthetics that acts quickly to relieve pain, itching and burning associated to hemorrhoidal disease.
ImmunoWay™ cough relief gummies, a substance-based medical device formulated in gummies. It is indicated to relieve cough (dry and productive), protect the mucosa of upper airways from the attack by external irritants and to favor the mucus clearance.
ShielDEFENCE™, immunobiotic gummies, a food supplement containing Lactobacillus paracasei MCC1849 and vitamins, specifically designed for consumers looking for ways to enhance their immune system and stay healthy throughout the year.
